Medtronic plc (MDT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-24. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 15B 30B 45B FY17: 29.7B FY18: 30B FY19: 30.6B FY20: 28.9B FY21: 30.1B FY22: 31.7B FY23: 31.2B FY24: 32.4B FY25: 33.5B FY26: 36.4B FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Gross Profit Annual

0 8B 16B 24B FY14: 12.7B FY15: 14B FY16: 19.7B FY17: 20.4B FY18: 20.9B FY14 FY15 FY16 FY17 FY18

Operating Income Annual

0 2.5B 5B 7.5B FY17: 5.4B FY18: 6.6B FY19: 6.3B FY20: 4.8B FY21: 4.5B FY22: 5.8B FY23: 5.5B FY24: 5.1B FY25: 6B FY26: 6.5B FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Net Income Annual

0 2B 4B 6B FY17: 4B FY18: 3.1B FY19: 4.6B FY20: 4.8B FY21: 3.6B FY22: 5B FY23: 3.8B FY24: 3.7B FY25: 4.7B FY26: 4.8B FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Cost of Revenue Annual

0 5B 10B 15B FY17: 9.3B FY18: 9.1B FY19: 9.2B FY20: 9.4B FY21: 10.5B FY22: 10.1B FY23: 10.7B FY24: 11.2B FY25: 11.6B FY26: 12.7B FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating Cash Flow Annual

0 2.5B 5B 7.5B FY17: 6.9B FY18: 4.7B FY19: 7B FY20: 7.2B FY21: 6.2B FY22: 7.3B FY23: 6B FY24: 6.8B FY25: 7B FY26: 7.3B FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Free Cash Flow Annual

0 2.5B 5B 7.5B FY17: 5.6B FY18: 3.6B FY19: 5.9B FY20: 6B FY21: 4.9B FY22: 6B FY23: 4.6B FY24: 5.2B FY25: 5.2B FY26: 5.4B FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 500M 1B 1.5B FY17: 1.4B FY18: 1.4B FY19: 1.4B FY20: 1.4B FY21: 1.4B FY22: 1.4B FY23: 1.3B FY24: 1.3B FY25: 1.3B FY26: 1.3B FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q1 '17: 2.57 Q2 '17: 3.01 Q3 '17: 2.83 Q4 '17: 2.89 Q1 '18: 2.97 Q2 '18: 3.65 Q3 '18: 2.03 Q4 '18: 2.26 Q1 '19: 2.31 Q2 '19: 1.65 Q3 '19: 3.62 Q4 '19: 3.42 Q1 '20: 3.27 Q2 '20: 3.46 Q3 '20: 3.94 Q4 '20: 3.55 Q1 '21: 3.27 Q2 '21: 2.62 Q3 '21: 2.14 Q4 '21: 2.66 Q1 '22: 2.86 Q2 '22: 3.47 Q3 '22: 3.63 Q4 '22: 3.73 Q1 '23: 3.87 Q2 '23: 3.22 Q3 '23: 3.04 Q4 '23: 2.82 Q1 '24: 2.71 Q2 '24: 3.07 Q3 '24: 3.14 Q4 '24: 2.75 Q1 '25: 2.96 Q2 '25: 3.27 Q3 '25: 3.29 Q4 '25: 3.62 Q1 '26: 3.63 Q2 '26: 3.71 Q3 '26: 3.59 Q4 '26: 3.74 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.